FinData: Share Price for NASDAQ, MATN - Mateon Therapeutics Inc.
MATEON'S C001- A GLOBAL PHASE 2 STUDY FOR OT-101 AGAINST
Mateon Therapeutics Company Profile: Valuation, Investors, Acquisition | PitchBook
Consulting Agreement by and between the Company and Artius, | MATEON THERAPEUTICS INC | Business Contracts | Justia
Mateon Therapeutics Archives - IndiaMedToday
Windlas Biotech and Mateon Therapeutics to launch combined lung therapy, AI Telemedicine solution - Express Healthcare
Windlas Biotech, Mateon Therapeutics bring lung therapy food supplement PulmoHeal - FFOODS Spectrum - Unleashing the Power of Food Science & Technology
NantCell Binding Termsheet | MATEON THERAPEUTICS INC | Business Contracts | Justia
Keeping an eye on Mateon Therapeutics (OTCQB: MATN) says GEN - Genetic Engineering & Biotechnology News - EmergingGrowth.com
A Covid-19 treatment plan slowly emerges | Evaluate
Windlas Biotech and Mateon Therapeutics Launch India's First Combined Lung Therapy and Ai Telemedicine 360 Solution to Transform Respiratory Wellness - The Pharma Times | Pharma & Health Care News Portal
About Us – Oncotelic
Windlas Biotech, Mateon Therapeutics launch integrated solution for respiratory wellness in India
Mateon Therapeutics
iBio Announces Collaboration with EdgePoint AI for Next Gen Biologics Manufacturing - DATAVERSITY
Combined CA4P (Fosbretabulin) therapy in Cancer- Ashini R. Dias, Contributor | Cancer Biology
Windlas Biotech and Mateon Therapeutics launch first-ever Drug-Device Lung Therapy Combined AI 360 platform for respiratory wellness - The Statesman
Articles about Mateon Therapeutics, Inc.
Mateon Completes Its Acquisition of PointR Data Inc. - DATAVERSITY
Blockchain-Fueled Company Mateon Develops Phase 3 Clinical Drug Candidate, Against COVID-19 - OT-101 – Blockchain News, Opinion, TV and Jobs
Joint Venture Agreement relating to GMP Biotechnology Limited | MATEON THERAPEUTICS INC | Business Contracts | Justia
Mateon Therapeutics
DEVELOPMENT UPDATE FOR ARTIVEDA™/ARTISHIELD™ AGAINST
MATEON THERAPEUTICS AKTIE | Aktienkurs | US6283411097 | News | A14Y0U | finanzen.net
Mateon | HealthWire
Mateon Therapeutics - BIO Investor Forum | BIO
